Home › Funds › GSA CAPITAL PARTNERS LLP › GILD

GSA CAPITAL PARTNERS LLP position in GILD

GILEAD SCIENCES INC · Health Care

GSA CAPITAL PARTNERS LLP reported holding 30,194 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.5M, representing 0.27% of its reported portfolio and ranking #17 among its reported holdings. GSA CAPITAL PARTNERS LLP has disclosed GILD holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)30.19K sh
Reported value held$4.50M
Portfolio Weight0.27%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How GSA CAPITAL PARTNERS LLP's GILD position evolved

GSA CAPITAL PARTNERS LLP first disclosed a stake in GILD in Q3 2023 at 3,603 shares (US$270K). The position peaked in Q3 2026 at 30,194 shares, worth US$4.5M. Across 7 filings, GSA CAPITAL PARTNERS LLP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 30,194 shares valued at US$4.5M — an increase of 20,317 shares quarter over quarter.. Notable position changes include a 205% increase in Q1 2026 (shares fell 10% over the following quarter), a 72% increase in Q2 2026 (shares rose 18% over the following quarter), a 206% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.60K $270.00K New
Q1 2024 6.30K $462.00K New
Q3 2025 3.04K $337.00K New
Q4 2025 1.88K $230.00K Reduce
Q1 2026 5.73K $798.00K Add
Q2 2026 9.88K $1.25M Add
Q3 2026 30.19K $4.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has GSA CAPITAL PARTNERS LLP held GILD?

GSA CAPITAL PARTNERS LLP has disclosed GILD holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

What is GSA CAPITAL PARTNERS LLP's current position in GILD?

As of Q3 2026, GSA CAPITAL PARTNERS LLP holds 30.19K shares of GILD (GILEAD SCIENCES INC), valued at $4.50M, representing 0.27% of its reported portfolio and ranking #17.

Has GSA CAPITAL PARTNERS LLP been buying or selling GILD?

In the latest 13F filing (Q3 2026), GSA CAPITAL PARTNERS LLP increased its position in GILD. The position peaked in Q3 2026 at 30.19K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.